Arkolith/Insider Trading/HCWB/Form 4

Wong Hing C

Chief Executive Officer, Director, 10% OwnerHCW Biologics Inc. (HCWB) · full profile →Form 4 · filed May 9, 2025
Net Buying
Open-Market Buys
$2.4M
Open-Market Sells
$0
Net Open-Market Flow
$2.4M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2025Buy(P)93K$26.00$2.4M494K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 7, 2025Buy(P)46K—$046K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-068292) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML